Juan Manuel Carreno
Overview
Explore the profile of Juan Manuel Carreno including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
1546
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carreno J, Lerman B, Singh G, Abbad A, Yellin T, Ehrenhaus J, et al.
mBio
. 2025 Mar;
:e0360724.
PMID: 40042313
The evolution of the antibody response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is impacted by the nature and number of antigenic exposures. First-generation coronavirus disease 2019 (COVID-19)...
2.
Abbad A, Yueh J, Yellin T, Singh G, Carreno J, Clark J, et al.
Vaccine
. 2025 Feb;
50:126825.
PMID: 39921982
The ongoing co-circulation of influenza viruses and severe acute respiratory disease coronavirus 2 (SARS-CoV-2) presents significant public health challenges. Vaccination is a pivotal tool to tackle infections and severe disease....
3.
Dolange V, Slamanig S, Abdeljawad A, Ying T, Lemus N, Singh G, et al.
J Infect Dis
. 2025 Jan;
PMID: 39749487
Background: The emergence of new SARS-CoV-2 variants poses a new challenge for the treatment of immunocompromised patients against COVID-19. In this context, high titer COVID-19 Convalescent Plasma (CCP) is one...
4.
Thiem V, Anh D, Ha V, Van Thom N, Thang T, Mateus J, et al.
Vaccine
. 2024 Nov;
44():126542.
PMID: 39615342
Production of affordable coronavirus disease 2019 (COVID-19) vaccines in low- and lower-middle-income countries is needed. NDV-HXP-S is an inactivated egg-based recombinant Newcastle disease virus vaccine expressing the spike protein of...
5.
Williams E, Echeverri Tribin F, Carreno J, Krammer F, Hoffer M, Pallikkuth S, et al.
Vaccine
. 2024 Nov;
43(Pt 1):126484.
PMID: 39520894
The severity of SARS-CoV-2 illness is influenced by factors including age, sex, pre-existing health conditions, and individual immune responses. However, the mechanisms conferring immunity following antigenic challenge have not been...
6.
Clark J, Hoxie I, Adelsberg D, Sapse I, Andreata-Santos R, Yong J, et al.
Cell Rep
. 2024 Nov;
43(11):114922.
PMID: 39504245
Neutralizing antibodies correlate with protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Recent studies, however, show that binding antibody titers, in the absence of robust neutralizing activity, also correlate...
7.
Somisetty M, Mack P, Hsu C, Huang Y, Gomez J, Rodilla A, et al.
Clin Lung Cancer
. 2024 Aug;
25(7):612-618.
PMID: 39122606
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may be spread by individuals unaware they are infected. Such dissemination has heightened ramifications in cancer patients, who may need to visit...
8.
Time-Dependent Effects of Clinical Interventions on SARS-CoV-2 Immunity in Patients with Lung Cancer
Mack P, Hsu C, Rodilla A, Gomez J, Cagan J, Huang Y, et al.
Vaccines (Basel)
. 2024 Jul;
12(7).
PMID: 39066351
In patients with lung cancer (LC), understanding factors that impact the dynamics of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) anti-spike antibody (SAb) titers over time is critical, but challenging,...
9.
Carreno J, Wagner A, Monahan B, Singh G, Floda D, Gonzalez-Reiche A, et al.
Nat Commun
. 2024 Jul;
15(1):5847.
PMID: 38992013
Sero-monitoring provides context to the epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and changes in population immunity following vaccine introduction. Here, we describe results of a cross-sectional...
10.
McIntire K, Meng H, Lin T, Kim W, Moore N, Han J, et al.
J Exp Med
. 2024 Jun;
221(8).
PMID: 38935072
Germinal centers (GC) are microanatomical lymphoid structures where affinity-matured memory B cells and long-lived bone marrow plasma cells are primarily generated. It is unclear how the maturation of B cells...